Filing Details
- Accession Number:
- 0001140361-10-012156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-16 13:00:00
- Reporting Period:
- 2010-03-15
- Filing Date:
- 2010-03-16
- Accepted Time:
- 2010-03-16 13:35:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 319240 | Iris International Inc | IRIS | Laboratory Analytical Instruments (3826) | 942579751 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408320 | Peter Donato | C/O Iris International, Inc. 9172 Eton Avenue Chatsworth CA 91311 | Corporate V.p. & C.f.o. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-03-15 | 146 | $10.39 | 10,885 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 146 | $10.40 | 10,739 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 146 | $10.40 | 10,593 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 146 | $10.41 | 10,447 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 146 | $10.42 | 10,301 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 146 | $10.42 | 10,155 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 146 | $10.44 | 10,009 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 146 | $10.52 | 9,863 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 145 | $10.53 | 9,718 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 292 | $10.53 | 9,426 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-15 | 146 | $10.55 | 9,280 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Billionaire Hedge Funds
